JP2023554467A5 - - Google Patents

Info

Publication number
JP2023554467A5
JP2023554467A5 JP2023537253A JP2023537253A JP2023554467A5 JP 2023554467 A5 JP2023554467 A5 JP 2023554467A5 JP 2023537253 A JP2023537253 A JP 2023537253A JP 2023537253 A JP2023537253 A JP 2023537253A JP 2023554467 A5 JP2023554467 A5 JP 2023554467A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023537253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023554467A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/138845 external-priority patent/WO2022127871A1/en
Publication of JP2023554467A publication Critical patent/JP2023554467A/ja
Publication of JP2023554467A5 publication Critical patent/JP2023554467A5/ja
Pending legal-status Critical Current

Links

JP2023537253A 2020-12-17 2021-12-16 Gucy2c結合分子及びその使用 Pending JP2023554467A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/137164 2020-12-17
CN2020137164 2020-12-17
PCT/CN2021/138845 WO2022127871A1 (en) 2020-12-17 2021-12-16 Gucy2c binding molecules and uses thereof

Publications (2)

Publication Number Publication Date
JP2023554467A JP2023554467A (ja) 2023-12-27
JP2023554467A5 true JP2023554467A5 (https=) 2025-01-08

Family

ID=82060074

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537253A Pending JP2023554467A (ja) 2020-12-17 2021-12-16 Gucy2c結合分子及びその使用

Country Status (15)

Country Link
US (1) US20240059794A1 (https=)
EP (1) EP4263615A4 (https=)
JP (1) JP2023554467A (https=)
KR (1) KR20230131183A (https=)
CN (2) CN118146381A (https=)
AU (1) AU2021404641A1 (https=)
BR (1) BR112023011658A2 (https=)
CA (1) CA3205007A1 (https=)
CL (1) CL2023001665A1 (https=)
CO (1) CO2023009279A2 (https=)
CR (1) CR20230245A (https=)
EC (1) ECSP23053774A (https=)
IL (1) IL303610A (https=)
MX (1) MX2023006969A (https=)
WO (1) WO2022127871A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202413437A (zh) * 2022-08-05 2024-04-01 大陸商江蘇恆瑞醫藥股份有限公司 特異性結合gucy2c和cd3的抗原結合分子及其醫藥用途
CN116751303B (zh) * 2022-12-09 2023-12-26 华道(上海)生物医药有限公司 一种抗鸟苷酸环化酶2c的纳米抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080764A2 (en) * 2007-12-20 2009-07-02 Abylnx N.V. Oral or nasal administration of compounds comprising amino acid sequences
US9156915B2 (en) * 2012-04-26 2015-10-13 Thomas Jefferson University Anti-GCC antibody molecules
AU2013251312B2 (en) * 2012-04-27 2018-03-22 Takeda Pharmaceutical Company Limited Anti-GCC antibody molecules and use of same to test for susceptibility to GCC-targeted therapy
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
CN109996872A (zh) * 2017-07-20 2019-07-09 深圳普瑞金生物药业有限公司 一种用于治疗肿瘤的egfr单域抗体cart及其应用
BR112020013244A2 (pt) * 2018-01-04 2020-12-01 Shanghai Lumosa Therapeutics Co., Ltd. proteínas de fusão de anticorpo citosina-desaminase de domínio único
MX2020012607A (es) * 2018-05-23 2021-01-29 Pfizer Anticuerpos especificos para gucy2c y sus usos.
US11981920B2 (en) * 2018-12-04 2024-05-14 Innovative Cellular Therapeutics Holdings, Ltd. Modified cell with enhanced migration capability

Similar Documents

Publication Publication Date Title
JP2021087455A5 (https=)
JP2025028239A5 (https=)
JP2021094037A5 (https=)
JP7724332B2 (ja) クローディン18.2結合部分およびその利用
JP2025065142A5 (https=)
JP2022542543A5 (https=)
HRP20241057T1 (hr) Kimerni antigenski receptori na osnovu jedno-domenskih antitijela i načini njihove uporabe
JP7503642B2 (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
CA3086653A1 (en) Tumor necrosis factor (tnf) receptor superfamily (tnfrsf) receptor-activating antibody fusion proteins with fcyr-independent agonistic activity (tnfrsf receptor-activating antibody fusion proteins with fcyr-independ ent agonistic activity; traaffiaa)
JP2021526844A5 (https=)
JP2020511947A5 (https=)
JP2016514457A5 (https=)
JP2023546764A5 (https=)
JP2018526981A5 (https=)
JP2023546766A5 (https=)
CN116390953A (zh) 靶向人密蛋白18.2的抗体及其用途
TW202241956A (zh) 新穎抗cd24抗體
JP2023543493A5 (https=)
JP2023525778A5 (https=)
JP2022513372A5 (https=)
JP2024504162A5 (https=)
JP2023554467A5 (https=)
JP2024539630A5 (https=)
JP2024507937A5 (https=)
JP2024541476A5 (https=)